HARVARD MANAGEMENT CO INC Diversified Active

Location: Boston, MA

CIK: 0001082621 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 13, 2021

Total Value: $1.738B (100.0% shares, 0.0% debt)

Holdings (38)

AAPL APPLE INC 19.2%

Value $333M Shares 2,434,903 Est. Cost — Unrealized —

RPRX ROYALTY PHARMA PLC 16.8%

Value $293M Shares 7,142,856 Est. Cost — Unrealized —

LNWO SCIENTIFIC GAMES CORP 11.9%

Value $207M Shares 2,678,571 Est. Cost — Unrealized —

META FACEBOOK INC 10.4%

Value $181M Shares 519,456 Est. Cost — Unrealized —

PANW PALO ALTO NETWORKS INC 5.3%

Value $91.26M Shares 245,943 Est. Cost — Unrealized —

ABCL ABCELLERA BIOLOGICS INC 5.2%

Value $90.31M Shares 4,105,095 Est. Cost — Unrealized —

ICE INTERCONTINENTAL EXCHANGE IN 4.7%

Value $81.73M Shares 688,549 Est. Cost — Unrealized —

RXRX RECURSION PHARMACEUTICALS IN 3.2%

Value $55.09M Shares 1,509,254 Est. Cost — Unrealized —

DVA DAVITA INC 2.8%

Value $49.24M Shares 408,912 Est. Cost — Unrealized —

TXG 10X GENOMICS INC 2.1%

Value $36.45M Shares 186,143 Est. Cost — Unrealized —

QQQ INVESCO QQQ TR 2.1%

Value $36.23M Shares 102,222 Est. Cost — Unrealized —

AFRM AFFIRM HLDGS INC 1.9%

Value $32.15M Shares 477,421 Est. Cost — Unrealized —

IVV ISHARES TR 1.6%

Value $28.09M Shares 65,342 Est. Cost — Unrealized —

PCT PURECYCLE TECHNOLOGIES INC 1.5%

Value $25.3M Shares 1,069,600 Est. Cost — Unrealized —

RVMD REVOLUTION MEDICINES INC 1.2%

Value $21.28M Shares 670,382 Est. Cost — Unrealized —

U UNITY SOFTWARE INC 1.2%

Value $20.47M Shares 186,396 Est. Cost — Unrealized —

RLAY RELAY THERAPEUTICS INC 1.1%

Value $19.8M Shares 541,124 Est. Cost — Unrealized —

PLRX PLIANT THERAPEUTICS INC 0.9%

Value $16.38M Shares 562,379 Est. Cost — Unrealized —

GLD SPDR GOLD TR 0.9%

Value $15.23M Shares 91,955 Est. Cost — Unrealized —

— PRAXIS PRECISION MEDICINES I 0.8%

Value $14.23M Shares 778,517 Est. Cost — Unrealized —

— GENERATION BIO CO 0.8%

Value $13.78M Shares 512,349 Est. Cost — Unrealized —

— KINNATE BIOPHARMA INC 0.7%

Value $11.59M Shares 498,001 Est. Cost — Unrealized —

SANA SANA BIOTECHNOLOGY INC 0.5%

Value $9.216M Shares 468,749 Est. Cost — Unrealized —

VEA VANGUARD TAX-MANAGED INTL FD 0.5%

Value $8.382M Shares 162,699 Est. Cost — Unrealized —

NRIX NURIX THERAPEUTICS INC 0.5%

Value $8.351M Shares 314,762 Est. Cost — Unrealized —

IJR ISHARES TR 0.3%

Value $5.703M Shares 50,474 Est. Cost — Unrealized —

FULC FULCRUM THERAPEUTICS INC 0.2%

Value $4.304M Shares 410,714 Est. Cost — Unrealized —

VWO VANGUARD INTL EQUITY INDEX F 0.2%

Value $4.008M Shares 73,804 Est. Cost — Unrealized —

— FS DEVELOPMENT CORP II 0.2%

Value $4M Shares 400,000 Est. Cost — Unrealized —

IJH ISHARES TR 0.2%

Value $3.408M Shares 12,683 Est. Cost — Unrealized —

— MAGENTA THERAPEUTICS INC 0.2%

Value $3.253M Shares 332,610 Est. Cost — Unrealized —

PDD PINDUODUO INC 0.2%

Value $3.238M Shares 25,493 Est. Cost — Unrealized —

— SERES THERAPEUTICS INC 0.2%

Value $3.145M Shares 131,847 Est. Cost — Unrealized —

— DECIBEL THERAPEUTICS INC 0.2%

Value $2.828M Shares 328,798 Est. Cost — Unrealized —

DYN DYNE THERAPEUTICS INC 0.1%

Value $2.257M Shares 107,252 Est. Cost — Unrealized —

— GEMINI THERAPEUTICS INC 0.1%

Value $1.618M Shares 250,000 Est. Cost — Unrealized —

— NUCANA PLC 0.1%

Value $1.072M Shares 387,124 Est. Cost — Unrealized —

QNCX CORTEXYME INC 0.0%

Value $156K Shares 2,937 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
AAPL	APPLE INC	2,434,903	$333M	19.2%	—	—	COM	037833100
RPRX	ROYALTY PHARMA PLC	7,142,856	$293M	16.8%	—	—	SHS CLASS A	G7709Q104
LNWO	SCIENTIFIC GAMES CORP	2,678,571	$207M	11.9%	—	—	COM	80874P109
META	FACEBOOK INC	519,456	$181M	10.4%	—	—	CL A	30303M102
PANW	PALO ALTO NETWORKS INC	245,943	$91.26M	5.3%	—	—	COM	697435105
ABCL	ABCELLERA BIOLOGICS INC	4,105,095	$90.31M	5.2%	—	—	COM	00288U106
ICE	INTERCONTINENTAL EXCHANGE IN	688,549	$81.73M	4.7%	—	—	COM	45866F104
RXRX	RECURSION PHARMACEUTICALS IN	1,509,254	$55.09M	3.2%	—	—	CL A	75629V104
DVA	DAVITA INC	408,912	$49.24M	2.8%	—	—	COM	23918K108
TXG	10X GENOMICS INC	186,143	$36.45M	2.1%	—	—	CL A COM	88025U109
QQQ	INVESCO QQQ TR	102,222	$36.23M	2.1%	—	—	UNIT SER 1	46090E103
AFRM	AFFIRM HLDGS INC	477,421	$32.15M	1.9%	—	—	COM CL A	00827B106
IVV	ISHARES TR	65,342	$28.09M	1.6%	—	—	CORE S&P500 ETF	464287200
PCT	PURECYCLE TECHNOLOGIES INC	1,069,600	$25.3M	1.5%	—	—	COM	74623V103
RVMD	REVOLUTION MEDICINES INC	670,382	$21.28M	1.2%	—	—	COM	76155X100
U	UNITY SOFTWARE INC	186,396	$20.47M	1.2%	—	—	COM	91332U101
RLAY	RELAY THERAPEUTICS INC	541,124	$19.8M	1.1%	—	—	COM	75943R102
PLRX	PLIANT THERAPEUTICS INC	562,379	$16.38M	0.9%	—	—	COM	729139105
GLD	SPDR GOLD TR	91,955	$15.23M	0.9%	—	—	GOLD SHS	78463V107
—	PRAXIS PRECISION MEDICINES I	778,517	$14.23M	0.8%	—	—	COM	74006W108
—	GENERATION BIO CO	512,349	$13.78M	0.8%	—	—	COM	37148K100
—	KINNATE BIOPHARMA INC	498,001	$11.59M	0.7%	—	—	COM	49705R105
SANA	SANA BIOTECHNOLOGY INC	468,749	$9.216M	0.5%	—	—	COM	799566104
VEA	VANGUARD TAX-MANAGED INTL FD	162,699	$8.382M	0.5%	—	—	FTSE DEV MKT ETF	921943858
NRIX	NURIX THERAPEUTICS INC	314,762	$8.351M	0.5%	—	—	COM	67080M103
IJR	ISHARES TR	50,474	$5.703M	0.3%	—	—	CORE S&P SCP ETF	464287804
FULC	FULCRUM THERAPEUTICS INC	410,714	$4.304M	0.2%	—	—	COM	359616109
VWO	VANGUARD INTL EQUITY INDEX F	73,804	$4.008M	0.2%	—	—	FTSE EMR MKT ETF	922042858
—	FS DEVELOPMENT CORP II	400,000	$4M	0.2%	—	—	COM CL A	30318F100
IJH	ISHARES TR	12,683	$3.408M	0.2%	—	—	CORE S&P MCP ETF	464287507
—	MAGENTA THERAPEUTICS INC	332,610	$3.253M	0.2%	—	—	COM	55910K108
PDD	PINDUODUO INC	25,493	$3.238M	0.2%	—	—	SPONSORED ADS	722304102
—	SERES THERAPEUTICS INC	131,847	$3.145M	0.2%	—	—	COM	81750R102
—	DECIBEL THERAPEUTICS INC	328,798	$2.828M	0.2%	—	—	COM	24343R106
DYN	DYNE THERAPEUTICS INC	107,252	$2.257M	0.1%	—	—	COM	26818M108
—	GEMINI THERAPEUTICS INC	250,000	$1.618M	0.1%	—	—	COM	36870G105
—	NUCANA PLC	387,124	$1.072M	0.1%	—	—	SPONSORED ADR	67022C106
QNCX	CORTEXYME INC	2,937	$156K	0.0%	—	—	COM	22053A107